Lung cancer

14 studies in Lung cancer

  1. A Phase IIB/III Randomized, Double-blind, Placebo Controlled Study Comparing First Line Therapy With or Without TG4010 Immunotherapy Product in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
    1. Arizona
  2. MC13C1, A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
    1. Minnesota
  3. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
    1. Arizona
  4. A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients With Acquired Resistance to Erlotinib
    1. Arizona,
    2. Minnesota
  5. Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    1. Minnesota
  6. A Pilot Study of Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
    1. Minnesota
  7. Randomized Phase II Trial of Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients With Early Stage Non-Small Lung Cancer (NSCLC)
    1. Minnesota
  8. Genetic Epidemiology Of Lung Cancer
    1. Minnesota
  9. Validation of a Multi-gene Test for Lung Cancer Risk
    1. Minnesota
  10. A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) Versus Docetaxel in Previously Treated Subjects With Non-Small Cell Lung Cancer
    1. Minnesota
  1. 1
  2. 2
  3. Next
Mar. 19, 2014

You Are ... The Campaign for Mayo Clinic

Mayo Clinic is a not-for-profit organization. Make a difference today.